We performed serial monitoring of CTC counts, mutation detection, and single-cell multiplex gene expression of CTCs from a prospective cohort of patients with NSCLC receiving EGFR-TKIs treatment. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.